Morgan Stanley Maintains Overweight on KLA, Lowers Price Target to $227
Morgan Stanley analyst Shane Brett maintains KLA (NASDAQ:KLAC) with a Overweight and lowers the price target from $253 to $227.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Morgan Stanley analyst Shane Brett maintains KLA (NASDAQ:KLAC) with a Overweight and lowers the price target from $253 to $227.
Teradyne's memory revenues hit a record $212M in Q2 2026, marking its third consecutive quarter above $200M, driven by strong demand for HBM, DRAM, and NAND testing. The company launched Magnum E2, a next-generation memory test system supporting advanced interfaces like LPDDR6, DDR6, GDDR7, and NAND. Management expects the 2026 memory test TAM to grow over 40% compared to 2025. However, TER stock trades at a premium valuation and faces competition from KLA and Cohu.
Dan Loeb’s Third Point exited five semiconductor holdings in Q2, while several of the stocks have since gained.